HOOKIPA appoints Terry Coelho to Board of Directors effective April 3, 2023

HOOKIPA Pharma Inc.

Terry Coelho appointed as Class III director, serving until the 2025 annual meeting.
She will serve on both the Audit Committee and Compensation Committee.
Ms. Coelho has over 35 years experience, including CFO roles at CinCor, BioDelivery Sciences, and Balchem.
Compensation includes an initial option for 19,200 shares, $40,000 annual cash retainer, plus committee retainers.
No other material arrangements or transactions exist with the new director.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Terry Coelho

Director

HOOK · HOOKIPA Pharma Inc.

Effective: 2023-04-03
Filed: March 13, 2023, 7:59 PM ET

On March 9, 2023, the Board of Directors (the “Board”) of HOOKIPA Pharma Inc. (the Company”) appointed Terry Coelho as a director of the Board, effective April 3, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Terry Coelho was appointed as Director at HOOKIPA Pharma Inc..

Action: appointed
Role: Director

Exact text from the filing

On March 9, 2023, the Board of Directors (the “Board”) of HOOKIPA Pharma Inc. (the Company”) appointed Terry Coelho as a director of the Board, effective April 3, 2023.

View on SEC.gov

HOOKIPA Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-031786

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.